Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Infection
Published in: Infection 5-6/2005

01-10-2005 | Clinical and Epidemiological Study

Antibiotic-Resistant Bloodstream Infections in Hospitalized Patients: Specific Risk Factors in a High–Risk Population?

Authors: Heike von Baum, J. F. Ober, C. Wendt, R. P. Wenzel, M. B. Edmond

Published in: Infection | Issue 5-6/2005

Login to get access
Metadata
Title
Antibiotic-Resistant Bloodstream Infections in Hospitalized Patients: Specific Risk Factors in a High–Risk Population?
Authors
Heike von Baum
J. F. Ober
C. Wendt
R. P. Wenzel
M. B. Edmond
Publication date
01-10-2005
Publisher
Urban & Vogel
Published in
Infection / Issue 5-6/2005
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-005-5066-4

Other articles of this Issue 5-6/2005

Infection 5-6/2005 Go to the issue

Case Report

Landouzy Septicemia (Sepsis Tuberculosa Acutissima) Due to Mycobacterium microti in an Immunocompetent Man

Clinical and Epidemiological Study

Prevalence of Clostridium difficile Toxins A and B and Clostridium perfringens Enterotoxin A in Stool Samples of Patients with Antibiotic–Associated Diarrhea

Brief Report

Inducible Metronidazole Resistance in nim–Positive and nim–Negative Bacteroides fragilis Group Strains after Several Passages Metronidazole Containing Columbia Agar Plates

Review

Dutch Guideline for Preventing Nosocomial Transmission of Highly Resistant Microorganisms (HRMO)

Clinical and Epidemiological Study

Incidence and Prognosis of CMV Disease in HIV–Infected Patients before and after Introduction of Combination Antiretroviral Therapy

Brief Report

In vitro Assessment of the Host Response against Enterococcus faecalis Used in Probiotic Preparations
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits